CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Morgan Stanley Adjusts Price Target on Gilead Sciences to $163 From $165

Neutral
AI Analysis

Summary

Morgan Stanley adjusted its price target on Gilead Sciences downward from $165 to $163 per share.

Importance:2/10
Sentiment:
-0.20
price_targetanalyst_ratingvaluation
Related Companies

Read the original article

Published by yahoo_finance on October 7, 2026 12:58 PM

Read Original